Why Expedia Group (EXPE) Stock Is Down Today

Expedia Group (EXPE) is down 5.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is profit-taking after a strong recent run, combined with broader market pressure on travel and consumer-facing stocks. There does not appear to be a new negative company-specific filing or earnings update driving the move, so this could be because investors are trimming positions ahead of management’s scheduled conference appearance on September 9, 2026.

Details:

Expedia’s latest major corporate update was its second-quarter release in early August, when it posted stronger bookings and revenue growth and raised parts of its 2026 outlook.

The company’s investor calendar shows a management appearance at the Goldman Sachs Communacopia + Technology Conference on September 9, 2026, which can lead some traders to reduce risk beforehand.

No fresh SEC filing or major new press release pointing to operational deterioration was easy to identify alongside today’s drop.

Broader U.S. equities were weaker today as rising oil prices and geopolitical concerns pressured sentiment, which can weigh on travel-related names.

Sources:

Expedia Group Investor Relations, SEC, AP, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$EXPE Insider Trading Activity

$EXPE insiders have traded $EXPE stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:

ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 4 sales selling 10,709 shares for an estimated $3,038,851.
LANCE A SOLIDAY (SVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,750 shares for an estimated $1,118,003.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$EXPE Hedge Fund Activity

We have seen 585 institutional investors add shares of $EXPE stock to their portfolio, and 625 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 2,417,016 shares (+inf%) to their portfolio in Q2 2026, for an estimated $618,466,054
PACER ADVISORS, INC. added 1,414,534 shares (+inf%) to their portfolio in Q2 2026, for an estimated $361,950,959
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 746,684 shares (+inf%) to their portfolio in Q2 2026, for an estimated $191,061,501
ALKEON CAPITAL MANAGEMENT LLC removed 650,000 shares (-26.3%) from their portfolio in Q2 2026, for an estimated $166,322,000
FIRST TRUST ADVISORS LP added 637,669 shares (+53.5%) to their portfolio in Q2 2026, for an estimated $163,166,743
BRIDGEWATER ASSOCIATES, LP removed 591,187 shares (-94.9%) from their portfolio in Q2 2026, for an estimated $151,272,929
BARCLAYS PLC added 562,948 shares (+90.9%) to their portfolio in Q2 2026, for an estimated $144,047,134

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$EXPE Congressional Stock Trading

Members of Congress have traded $EXPE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$EXPE Analyst Ratings

Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 05/08/2026

To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.

$EXPE Price Targets

Multiple analysts have issued price targets for $EXPE recently. We have seen 12 analysts offer price targets for $EXPE in the last 6 months, with a median target of $277.0.

Here are some recent targets:

John Staszak from Argus Research set a target price of $315.0 on 07/07/2026
Ken Gawrelski from Wells Fargo set a target price of $303.0 on 06/30/2026
Jake Fuller from BTIG set a target price of $330.0 on 06/09/2026
Tom White from DA Davidson set a target price of $250.0 on 05/18/2026
Shyam Patil from Susquehanna set a target price of $250.0 on 05/11/2026
Trevor Young from Barclays set a target price of $264.0 on 05/11/2026
Stephen Ju from UBS set a target price of $262.0 on 05/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.